Insider Trading
Current insider transactions (SEC Form 4) — buys and sells by officers, directors, and major shareholders.
| Ticker | Insider | Title | Date | Transaction | Price ($) | Shares | Value ($) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| SO | Spainhour Sterling A Jr. | EVP & CLO | 08/06/2026 | Verkauf | 94.02 | 3,333 | 313,369 | Form 4 |
| SIRI | Procope Jonelle | Director | 08/06/2026 | Verkauf | 29.97 | 16,672 | 499,702 | Form 4 |
| SI | Gilde Healthcare Holding B.V. | 10% Owner | 08/06/2026 | Verkauf | 22.60 | 2,095 | 47,347 | Form 4 |
| SCHL | Henderson Kaya | Director | 08/06/2026 | Verkauf | 40.25 | 3,250 | 130,813 | Form 4 |
| SCHL | Quinton Sasha | EVP, Pres. CBG | 08/06/2026 | Verkauf | 42.05 | 2,410 | 101,333 | Form 4 |
| SCHL | Quinton Sasha | EVP, Pres. CBG | 08/06/2026 | Verkauf | 41.74 | 5,139 | 214,492 | Form 4 |
| SARO | Ford Russell Wayne | Chief Executive Officer | 08/05/2026 | Verkauf | 30.89 | 40,000 | 1,235,604 | Form 4 |
| SSB | Brooks David R | Director | 08/05/2026 | Verkauf | 110.00 | 3,750 | 412,500 | Form 4 |
| SSB | Brooks David R | Director | 08/05/2026 | Verkauf | 110.00 | 1,100 | 121,000 | Form 4 |
| SSB | Brooks David R | Director | 08/05/2026 | Verkauf | 110.00 | 1,800 | 198,000 | Form 4 |
| SSB | Brooks David R | Director | 08/05/2026 | Verkauf | 110.00 | 18,000 | 1,980,000 | Form 4 |
| SN | Barrocas Mark | Chief Executive Officer | 08/05/2026 | Verkauf | 170.00 | 250,000 | 42,500,000 | Form 4 |
| SVV | Medway Richard A. | General Counsel | 08/05/2026 | Verkauf | 10.98 | 10,000 | 109,800 | Form 4 |
| SVV | Geisser Melinda L. | Chief People Services Officer | 08/05/2026 | Verkauf | 10.98 | 15,000 | 164,700 | Form 4 |
| SVV | Walsh Mark T. | CEO & Director | 08/05/2026 | Verkauf | 11.02 | 7,941 | 87,548 | Form 4 |
| SOPH | Xu Zhenyu | Chief Scientific Officer | 08/05/2026 | Verkauf | 7.00 | 3,000 | 21,013 | Form 4 |
| SI | Gilde Healthcare Holding B.V. | 10% Owner | 08/05/2026 | Verkauf | 22.64 | 7,338 | 166,132 | Form 4 |
| SCHW | Schwab-Pomerantz Carolyn | Director | 08/05/2026 | Verkauf | 107.70 | 18,561 | 1,999,016 | Form 4 |
| SCHW | Craig Jonathan M. | MD, Head of Retail Investing | 08/05/2026 | Verkauf | 107.02 | 21,750 | 2,327,752 | Form 4 |
| SCHL | Quinton Sasha | EVP, Pres. CBG | 08/05/2026 | Verkauf | 43.17 | 20,488 | 884,426 | Form 4 |
| SNX | Hume Richard T | Director | 08/05/2026 | Verkauf | 264.45 | 1,212 | 320,513 | Form 4 |
| SNX | Hume Richard T | Director | 08/05/2026 | Verkauf | 263.33 | 907 | 238,840 | Form 4 |
| SNX | Hume Richard T | Director | 08/05/2026 | Verkauf | 262.46 | 635 | 166,662 | Form 4 |
| SNX | Hume Richard T | Director | 08/05/2026 | Verkauf | 261.53 | 818 | 213,932 | Form 4 |
| SNX | Hume Richard T | Director | 08/05/2026 | Verkauf | 260.53 | 668 | 174,034 | Form 4 |
| SNX | Hume Richard T | Director | 08/05/2026 | Verkauf | 259.48 | 587 | 152,315 | Form 4 |
| SNX | Hume Richard T | Director | 08/05/2026 | Verkauf | 258.70 | 173 | 44,755 | Form 4 |
| SNEX | Fowler John Moore | Director | 08/05/2026 | Verkauf | 75.41 | 1,575 | 118,771 | Form 4 |
| SBUX | Brewer Brady | ceo, International | 08/05/2026 | Verkauf | 105.99 | 2,229 | 236,252 | Form 4 |
| SXT | Ferruzzi Mario | Director | 08/05/2026 | Verkauf | 129.48 | 1,200 | 155,372 | Form 4 |
| SEIC | McCabe Philip | See Remarks | 08/05/2026 | Verkauf | 105.50 | 5,043 | 532,037 | Form 4 |
| SMR | Fisher Carl M. | Chief Operating Officer | 08/05/2026 | Verkauf | 9.36 | 18,771 | 175,734 | Form 4 |
| SHOO | Varela Amelia | President | 08/05/2026 | Verkauf | 48.59 | 15,000 | 728,801 | Form 4 |
| SHOO | Reed Arian Simone | Director | 08/05/2026 | Verkauf | 48.76 | 1,250 | 60,950 | Form 4 |
| SHOO | Klipper Mitchell S | Director | 08/05/2026 | Verkauf | 48.54 | 3,918 | 190,186 | Form 4 |
| SCCO | Palomino Bonilla Luis Miguel | Director | 08/05/2026 | Verkauf | 200.00 | 100 | 20,000 | Form 4 |
| SEIC | McCabe Philip | See Remarks | 08/04/2026 | Verkauf | 105.04 | 24,957 | 2,621,433 | Form 4 |
| SARO | Ford Russell Wayne | Chief Executive Officer | 08/04/2026 | Verkauf | 30.24 | 40,000 | 1,209,524 | Form 4 |
| SFM | Sinclair Jack | Chief Executive Officer | 08/04/2026 | Verkauf | 86.80 | 10,788 | 936,364 | Form 4 |
| SLDE | Gries Robert JR | Director | 08/04/2026 | Verkauf | 20.44 | 28,212 | 576,653 | Form 4 |
| SSD | Andrasick James S | Director | 08/04/2026 | Verkauf | 195.62 | 800 | 156,496 | Form 4 |
| SNDR | Rourke Mark B. | Executive Chair | 08/04/2026 | Verkauf | 35.58 | 13,208 | 469,886 | Form 4 |
| SNDR | Rourke Mark B. | Executive Chair | 08/04/2026 | Verkauf | 35.98 | 15,474 | 556,747 | Form 4 |
| SNDR | Rourke Mark B. | Executive Chair | 08/04/2026 | Verkauf | 36.12 | 24,000 | 866,983 | Form 4 |
| SCCO | Palomino Bonilla Luis Miguel | Director | 08/04/2026 | Verkauf | 195.00 | 100 | 19,500 | Form 4 |
| SPFI | Campbell Richard D | Director | 08/04/2026 | Verkauf | 45.14 | 27,286 | 1,231,690 | Form 4 |
| SOPH | Verma Abhimanyu | Chief Technology Officer | 08/04/2026 | Verkauf | 6.95 | 5,000 | 34,772 | Form 4 |
| SOPH | Camblong Jurgi | Executive Chairman | 08/04/2026 | Verkauf | 6.92 | 20,000 | 138,412 | Form 4 |
| SOPH | Xu Zhenyu | Chief Scientific Officer | 08/04/2026 | Verkauf | 6.92 | 10,000 | 69,168 | Form 4 |
| SI | Gilde Healthcare Holding B.V. | 10% Owner | 08/04/2026 | Verkauf | 22.77 | 99,812 | 2,272,719 | Form 4 |
| SCHW | Schwab-Pomerantz Carolyn | Director | 08/04/2026 | Verkauf | 106.36 | 22,640 | 2,408,036 | Form 4 |
| SHOO | Ferrara Al | Director | 08/04/2026 | Verkauf | 48.26 | 3,918 | 189,083 | Form 4 |
| SHOO | Davis Peter Allan | Director | 08/04/2026 | Verkauf | 48.31 | 525 | 25,360 | Form 4 |
| SMBK | Jordan Rhett D. | EVP & CHIEF CREDIT OFFICER | 08/04/2026 | Verkauf | 52.75 | 430 | 22,683 | Form 4 |
| SMHI | Everett Andrew H II | Sr. VP, General Counsel & Secy | 08/04/2026 | Verkauf | 9.56 | 1,018 | 9,732 | Form 4 |
| SCHW | Schwab Charles R. | Co-Chairman | 08/04/2026 | Verkauf | 106.08 | 47,650 | 5,054,569 | Form 4 |
| STOK | Ticho Barry | CHIEF MEDICAL OFFICER | 08/03/2026 | Verkauf | 29.45 | 1,269 | 37,377 | Form 4 |
| STOK | Ticho Barry | CHIEF MEDICAL OFFICER | 08/03/2026 | Verkauf | 28.95 | 5,907 | 171,008 | Form 4 |
| SFIX | Bacos Anthony | Chief Prod/Technology Officer | 08/03/2026 | Verkauf | 4.09 | 20,000 | 81,722 | Form 4 |
| SFIX | Bacos Anthony | Chief Prod/Technology Officer | 08/03/2026 | Verkauf | 4.09 | 50,000 | 204,355 | Form 4 |
A compact market overview — not investment advice. Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q).